2024-05-08 23:11:07 ET
Amphastar Pharmaceuticals, Inc. (AMPH)
Q1 2024 Earnings Conference Call
May 8, 2024 17:00 ET
Company Participants
Dan Dischner - Senior Vice President of Corporate Communications
William Peters - Chief Financial Officer
Conference Call Participants
Ekaterina Knyazkova - JPMorgan
Timothy Chiang - Capital One
Pavan Patel - Bank of America
Presentation
Operator
Greetings and welcome to the Amphastar Pharmaceuticals' First Quarter Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions]
Please note that certain statements made during this call regarding matters that are not historical facts, including but not limited to, management's outlook or predictions for future periods are forward-looking statements. These statements are based solely on information that is now available to us. We encourage you to review the section entitled forward-looking statements in the press release issued today and the presentation on the company's website. Also, please refer to our SEC filings which can be found on our website and the SEC's website for a discussion of numerous factors that may impact our future performance. We will also discuss certain non-GAAP measures. Important information are on our use of these measures and reconciliations to U.S. GAAP may be found in our earnings release.
Please note, this conference call is being recorded. Our speakers today are Mr. Bill Peters, CFO; Mr. Dan Dischner, Senior Vice President of Corporate Communications; and Mr. Tony Marrs, Executive Vice President of Regulatory Affairs and Clinical Operations....
Read the full article on Seeking Alpha
For further details see:
Amphastar Pharmaceuticals, Inc. (AMPH) Q1 2024 Earnings Call Transcript